Chakravarty, D. & Solit, D. B. Clinical cancer genomic profiling. Nat. Rev. Genet. 22, 483–501 (2021).Article
CAS
PubMed
Google Scholar
Schreiber, S. L. A chemical biology view of bioactive small molecules and a binder-based approach to connect biology to precision medicines. Isr. J. Chem. 59, 52–59 (2019).Article
CAS
PubMed
Google Scholar
Wang, Z. Z., Shi, X. X., Huang, G. Y., Hao, G. F. & Yang, G. F. Fragment-based drug discovery supports drugging ‘undruggable’ protein-protein interactions. Trends Biochem. Sci. 48, 539–552 (2023).Article
CAS
PubMed
Google Scholar
St Denis, J. D., Hall, R. J., Murray, C. W., Heightman, T. D. & Rees, D. C. Fragment-based drug discovery: opportunities for organic synthesis. RSC Med. Chem. 12, 321–329 (2020).Article
Google Scholar
Lundquist, K. P., Panchal, V., Gotfredsen, C. H., Brenk, R. & Clausen, M. H. Fragment-based drug discovery for RNA targets. ChemMedChem 16, 2588–2603 (2021).Article
CAS
PubMed
Google Scholar
Erlanson, D. A., Davis, B. J. & Jahnke, W. Fragment-based drug discovery: advancing fragments in the absence of crystal structures. Cell Chem. Biol. 26, 9–15 (2019).Article
CAS
PubMed
Google Scholar
Bon, M., Bilsland, A., Bower, J. & McAulay, K. Fragment-based drug discovery-the importance of high-quality molecule libraries. Mol. Oncol. 16, 3761–3777 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Wen, X., Wu, X., Jin, R. & Lu, X. Privileged heterocycles for DNA-encoded library design and hit-to-lead optimization. Eur. J. Med. Chem. 248, 115079 (2023).Article
CAS
PubMed
Google Scholar
Shi, B., Zhou, Y., Huang, Y., Zhang, J. & Li, X. Recent advances on the encoding and selection methods of DNA-encoded chemical library. Bioorg. Med. Chem. Lett. 27, 361–369 (2017).Article
CAS
PubMed
Google Scholar
Peterson, A. A. & Liu, D. R. Small-molecule discovery through DNA-encoded libraries. Nat. Rev. Drug Discov. 22, 699–722 (2023).Article
CAS
PubMed
PubMed Central
Google Scholar
Chan, W. C., Sharifzadeh, S., Buhrlage, S. J. & Marto, J. A. Chemoproteomic methods for covalent drug discovery. Chem. Soc. Rev. 50, 8361–8381 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Spradlin, J. N., Zhang, E. & Nomura, D. K. Reimagining druggability using chemoproteomic platforms. Acc. Chem. Res. 54, 1801–1813 (2021).Article
CAS
PubMed
Google Scholar
Cuesta, A. & Taunton, J. Lysine-targeted inhibitors and chemoproteomic probes. Annu. Rev. Biochem. 88, 365–381 (2019).Article
CAS
PubMed
Google Scholar
Singh, J., Petter, R. C., Baillie, T. A. & Whitty, A. The resurgence of covalent drugs. Nat. Rev. Drug Discov. 10, 307–317 (2011).Article
CAS
PubMed
Google Scholar
Boike, L., Henning, N. J. & Nomura, D. K. Advances in covalent drug discovery. Nat. Rev. Drug Discov. 21, 881–898 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Cross, D. A. et al. AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Discov. 4, 1046–1061 (2014).Article
CAS
PubMed
PubMed Central
Google Scholar
Wang, M. L. et al. Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N. Engl. J. Med. 369, 507–516 (2013).Article
CAS
PubMed
PubMed Central
Google Scholar
Abdeldayem, A., Raouf, Y. S., Constantinescu, S. N., Moriggl, R. & Gunning, P. T. Advances in covalent kinase inhibitors. Chem. Soc. Rev. 49, 2617–2687 (2020).Article
CAS
PubMed
Google Scholar
Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A. & Shokat, K. M. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature 503, 548–551 (2013).Article
CAS
PubMed
PubMed Central
Google Scholar
Hong, D. S. et al. KRAS(G12C) inhibition with sotorasib in advanced solid tumors. N. Engl. J. Med. 383, 1207–1217 (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Backus, K. M. et al. Proteome-wide covalent ligand discovery in native biological systems. Nature 534, 570–574 (2016).Article
CAS
PubMed
PubMed Central
Google Scholar
Vinogradova, E. V. et al. An activity-guided map of electrophile-cysteine interactions in primary human T cells. Cell 182, 1009–1026 (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Abbasov, M. E. et al. A proteome-wide atlas of lysine-reactive chemistry. Nat. Chem. 13, 1081–1092 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Wang, C., Weerapana, E., Blewett, M. M. & Cravatt, B. F. A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles. Nat. Methods 11, 79–85 (2014).Article
PubMed
Google Scholar
Chen, Y. et al. Direct mapping of ligandable tyrosines and lysines in cells with chiral sulfonyl fluoride probes. Nat. Chem. 15, 1616–1625 (2023).Article
CAS
PubMed
Google Scholar
Maurais, A. J. & Weerapana, E. Reactive-cysteine profiling for drug discovery. Curr. Opin. Chem. Biol. 50, 29–36 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Weerapana, E. et al. Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature 468, 790–795 (2010).Article
CAS
PubMed
PubMed Central
Google Scholar
Gygi, S. P. et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994–999 (1999).Article
CAS
PubMed
Google Scholar
Kuljanin, M. et al. Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries. Nat. Biotechnol. 39, 630–641 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Grossman, E. A. et al. Covalent ligand discovery against druggable hotspots targeted by anti-cancer natural products. Cell Chem. Biol. 24, 1368–1376.e4 (2017).Article
CAS
PubMed
PubMed Central
Google Scholar
Lazear, M. R. et al. Proteomic discovery of chemical probes that perturb protein complexes in human cells. Mol. Cell 83, 1725–1742 (2023).Article
CAS
PubMed
Google Scholar
Tao, Y. et al. Targeted protein degradation by electrophilic PROTACs that stereoselectively and site-specifically engage DCAF1. J. Am. Chem. Soc. 144, 18688–18699 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Feldman, H. C. et al. Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain. Proc. Natl Acad. Sci. USA 119, e2208457119 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Kathman, S. G. et al. Remodeling oncogenic transcriptomes by small molecules targeting NONO. Nat. Chem. Biol. 19, 825–836 (2023).Article
CAS
PubMed
PubMed Central
Google Scholar
Boike, L. et al. Discovery of a functional covalent ligand targeting an intrinsically disordered cysteine within MYC. Cell Chem. Biol. 28, 4–13.e17 (2021).Article
CAS
PubMed
Google Scholar
Kavanagh, M. E. et al. Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine. Nat. Chem. Biol. 18, 1388–1398 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Darabedian, N. et al. Depletion of creatine phosphagen energetics with a covalent creatine kinase inhibitor. Nat. Chem. Biol. 19, 815–824 (2023).Article
CAS
PubMed
PubMed Central
Google Scholar
Bar-Peled, L. et al. Chemical proteomics identifies druggable vulnerabilities in a genetically defined cancer. Cell 171, 696–709.e23 (2017).Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang, X., Crowley, V. M., Wucherpfennig, T. G., Dix, M. M. & Cravatt, B. F. Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16. Nat. Chem. Biol. 15, 737–746 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang, X. et al. DCAF11 supports targeted protein degradation by electrophilic proteolysis-targeting chimeras. J. Am. Chem. Soc. 143, 5141–5149 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Ward, C. C. et al. Covalent ligand screening uncovers a RNF4 E3 ligase recruiter for targeted protein degradation applications. ACS Chem. Biol. 14, 2430–2440 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Gao, Z., Chang, C., Yang, J., Zhu, Y. & Fu, Y. AP3: an advanced proteotypic peptide predictor for targeted proteomics by incorporating peptide digestibility. Anal. Chem. 91, 8705–8711 (2019).Article
CAS
PubMed
Google Scholar
Lanning, B. R. et al. A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors. Nat. Chem. Biol. 10, 760–767 (2014).Article
CAS
PubMed
PubMed Central
Google Scholar
Niessen, S. et al. Proteome-wide map of targets of T790M-EGFR-directed covalent inhibitors. Cell Chem. Biol. 24, 1388–1400 (2017).Article
CAS
PubMed
PubMed Central
Google Scholar
Warren, A. et al. Global computational alignment of tumor and cell line transcriptional profiles. Nat. Commun. 12, 22 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Rostovtsev, V. V., Green, L. G., Fokin, V. V. & Sharpless, K. B. A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective ‘ligation’ of azides and terminal alkynes. Angew. Chem. Int. Ed. 41, 2596–2599 (2002).Article
CAS
Google Scholar
Tornoe, C. W., Christensen, C. & Meldal, M. Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem. 67, 3057–3064 (2002).Speers, A. E., Adam, G. C. & Cravatt, B. F. Activity-based protein profiling in vivo using a copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition. J. Am. Chem. Soc. 125, 4686–4687 (2003).Teng, M., Zhou, S., Cai, C., Lupien, M. & He, H. H. Pioneer of prostate cancer: past, present and the future of FOXA1. Protein Cell 12, 29–38 (2021).Article
CAS
PubMed
Google Scholar
Vinogradova, E. V. & Cravatt, B. F. Multiplexed proteomic profiling of cysteine reactivity and ligandability in human T cells. STAR Protoc. 2, 100458 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564–576 (2017).Article
CAS
PubMed
PubMed Central
Google Scholar
Serrano, G., Guruceaga, E. & Segura, V. DeepMSPeptide: peptide detectability prediction using deep learning. Bioinformatics 36, 1279–1280 (2020).Article
CAS
PubMed
Google Scholar
Li, H. et al. Assigning functionality to cysteines by base editing of cancer dependency genes. Nat. Chem. Biol. 19, 1320–1330 (2023).Article
CAS
PubMed
PubMed Central
Google Scholar
Taylor, C. A. T. et al. Domain-swapping switch point in Ste20 protein kinase SPAK. Biochemistry 54, 5063–5071 (2015).Article
CAS
PubMed
Google Scholar
Davis, I. & Liu, A. What is the tryptophan kynurenine pathway and why is it important to neurotherapeutics? Expert Rev. Neurother. 15, 719–721 (2015).Article
CAS
PubMed
PubMed Central
Google Scholar
Tan, L., Yu, J. T. & Tan, L. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations. J. Neurol. Sci. 323, 1–8 (2012).Article
CAS
PubMed
Google Scholar
Dewulf, J. P. et al. Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19. Sci. Rep. 12, 9959 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Thomas, T. et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight 5, e140327 (2020).Article
PubMed
PubMed Central
Google Scholar
Varadi, M. et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 50, D439–D444 (2022).Article
CAS
PubMed
Google Scholar
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Hu, L. J. et al. A simple HPLC-MS/MS method for determination of tryptophan, kynurenine and kynurenic acid in human serum and its potential for monitoring antidepressant therapy. J. Anal. Toxicol. 41, 37–44 (2017).Article
CAS
PubMed
Google Scholar
Dobrovolsky, V. N. et al. Effect of arylformamidase (kynurenine formamidase) gene inactivation in mice on enzymatic activity, kynurenine pathway metabolites and phenotype. Biochim. Biophys. Acta 1724, 163–172 (2005).Article
CAS
PubMed
Google Scholar
Bachovchin, D. A. et al. Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus-library screening. Proc. Natl Acad. Sci. USA 107, 20941–20946 (2010).Article
CAS
PubMed
PubMed Central
Google Scholar
Westhorpe, F. G., Tighe, A., Lara-Gonzalez, P. & Taylor, S. S. p31comet-mediated extraction of Mad2 from the MCC promotes efficient mitotic exit. J. Cell Sci. 124, 3905–3916 (2011).Article
CAS
PubMed
PubMed Central
Google Scholar
Hagan, R. S. et al. p31comet acts to ensure timely spindle checkpoint silencing subsequent to kinetochore attachment. Mol. Biol. Cell 22, 4236–4246 (2011).Article
CAS
PubMed
PubMed Central
Google Scholar
Lok, T. M. et al. Mitotic slippage is determined by p31comet and the weakening of the spindle-assembly checkpoint. Oncogene 39, 2819–2834 (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Yang, M. et al. p31comet blocks Mad2 activation through structural mimicry. Cell 131, 744–755 (2007).Article
CAS
PubMed
PubMed Central
Google Scholar
Abdel-Salam, G. M. H. et al. Biallelic MAD2L1BP (p31comet) mutation is associated with mosaic aneuploidy and juvenile granulosa cell tumors. JCI Insight 8, e170079 (2023).Article
PubMed
PubMed Central
Google Scholar
Browne, C. M. et al. A chemoproteomic strategy for direct and proteome-wide covalent inhibitor target-site identification. J. Am. Chem. Soc. 141, 191–203 (2019).Article
CAS
PubMed
Google Scholar
Wozniak, J. M. et al. Enhanced mapping of small-molecule binding sites in cells. Nat. Chem. Biol. 20, 823–834 (2024).Article
CAS
PubMed
PubMed Central
Google Scholar
Mons, E., Kim, R. Q. & Mulder, M. P. C. Technologies for direct detection of covalent protein–drug adducts. Pharmaceuticals 16, 547 (2023).Giansanti, P., Tsiatsiani, L., Low, T. Y. & Heck, A. J. Six alternative proteases for mass spectrometry-based proteomics beyond trypsin. Nat. Protoc. 11, 993–1006 (2016).Article
CAS
PubMed
Google Scholar
Abegg, D. et al. Chemoproteomic profiling by cysteine fluoroalkylation reveals myrocin G as an inhibitor of the nonhomologous end joining DNA repair pathway. J. Am. Chem. Soc. 143, 20332–20342 (2021).Article
CAS
PubMed
Google Scholar
Tessier, R. et al. Ethynylation of cysteine residues: from peptides to proteins in vitro and in living cells. Angew. Chem. Int. Ed. 59, 10961–10970 (2020).Article
CAS
Google Scholar
Motiwala, H. F., Kuo, Y. H., Stinger, B. L., Palfey, B. A. & Martin, B. R. Tunable heteroaromatic sulfones enhance in-cell cysteine profiling. J. Am. Chem. Soc. 142, 1801–1810 (2020).Article
CAS
PubMed
Google Scholar
Cuesta, A., Wan, X., Burlingame, A. L. & Taunton, J. Ligand conformational bias drives enantioselective modification of a surface-exposed lysine on Hsp90. J. Am. Chem. Soc. 142, 3392–3400 (2020).Article
CAS
PubMed
Google Scholar
Wang, Y. et al. Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs. Nat. Chem. 11, 1113–1123 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Jacobs, A. T. & Marnett, L. J. Systems analysis of protein modification and cellular responses induced by electrophile stress. Acc. Chem. Res. 43, 673–683 (2010).Article
CAS
PubMed
PubMed Central
Google Scholar
Békés, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181–200 (2022).Article
PubMed
PubMed Central
Google Scholar
Zhang, Y. et al. Expanding the ligandable proteome by paralog hopping with covalent probes. Preprint at bioRxiv https://doi.org/10.1101/2024.01.18.576274 (2024).Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543–D552 (2022).Article
CAS
PubMed
Google Scholar